Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...
You are here: Home » News
Print

Interviews with Executive Editor of ChinaBio® Today and founder of ChinaBio LLC, Greg Scott, and articles on ChinaBio's events and activities in China and US...

Greg Scott and other industry leaders quoted in Nature News
November 10, 2009
 
Greg Scott presents at ChinaBio Executive Workshop
during the 2009 JPMorgan Healthcare Conference
January 13, 2009
Hosted by: www.essinova.com
on The Frank Peters Show
October 6, 2008
 
October 2, 2008
China’s Evolving Biotech Industry
May 15, 2008
VC Investment: China vs U.S.
March 20, 2008
State of China Biotech Industry
 
CCTV-9 BizCHINA Interview

CCTV-9 BizCHINA Pharma Industry
March 10-15, 2008

China: Dragon Lures Foreign Investors
StartUp Magazine
February, 2008
>> Free Preview

Interfax Interviews with Greg Scott:
China's Medical Device and Biotechnology Sectors
December, 2007
China Biomedical Investing Gaining Momentum
November, 2007

Recent Articles

  INDs and NDAs Quantify the Innovation in China’s Drug R&D
Jun 10, 2011
Do we know how much innovation exists in China’s drug R&D sector? To get some data on the matter, the journal Nature recently published an article that counted the number of INDs and NDAs approved by the SFDA in recent years. Their answer? During the eight years from 2003-10, the SFDA allowed an average of about 25 innovative drugs each year to begin clinical trials (INDs), and it approved for marketing about four new drugs per year (NDAs). More details....

Share this with colleagues:  
  Tasly Pharma to Make $40 Million Investment in US Facility
Jun 2, 2011
Tianjin Tasly Pharma announced it will invest $40 million into a US facility that will support its TCM-based treatment for coronary disease, known as Compound Danshen Dripping Pills (CDDP). The company will build a 430,000 square foot production facility and training center near Washington DC, in a life sciences park located in Maryland. CDDP successfully completed a Phase II trial in early 2010. The company is planning a 2,000 patient Phase III trial that is expected to begin this year. More details....

Stock Symbol: (SHA: 600535)     Share this with colleagues:  

 
  ChinaBio® Partnering Forum Draws 558 Attendees
Jul 1, 2010
SUZHOU, China--The Second Annual ChinaBio® Partnering Forum 2010, held June 23-24 in Suzhou, China, generated a very successful round of meetings, according to co-organizers ChinaBio® LLC and EBD Group. This year’s Partnering Forum was host to 337 companies from 23 countries. At least 654 one-to-one meetings were held between the 558 attendees. The event was hosted by BioBay life science park. More details...
 
Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners